| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Bremelanotide (Vyleesi) (CP.PHAR.434) - RETIRED (Ambetter December 1, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Handling Authorizations for Transportation (TX.UM.10.07) - RETIRED (Medicaid November 1, 2021 | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Mogamulizumab-kpkc (Poteligeo) (CP.PHAR.139) - RETIRED (Medicaid October 18, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Rituximab - Effective 11/1/2017 (CP.PHAR.260) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Naloxone (Evzio) (CP.PMN.139) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Influenza Testing | |
| Meridian Illinois Medicaid Clinical | Aflibercept (Eylea) (CP.PHAR.184) | |
| Meridian Illinois Medicaid Clinical | Belantamab Mafodotin (Blenrep) (CP.PHAR.469) | |
| Meridian Illinois Medicaid Clinical | Ciltacabtagene Autoleucel (CP.PHAR.533) | |
| Meridian Illinois Medicaid Clinical | Copanlisib (Aliqopa) (CP.PHAR.357) | |